Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH
Authors
Keywords
-
Journal
Scientific Reports
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-01-28
DOI
10.1038/s41598-023-28647-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breakthroughs in therapies for NASH and remaining challenges
- (2022) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits
- (2022) Moritz Peiseler et al. JOURNAL OF HEPATOLOGY
- Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling
- (2022) Silvia Marchianò et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH
- (2022) Darren Jun Hao Tan et al. HEPATOLOGY
- Efficacy and safety of drugs for nonalcoholic steatohepatitis
- (2021) Bo Shen et al. Journal of Digestive Diseases
- Vertical sleeve gastrectomy confers metabolic improvements by reducing intestinal bile acids and lipid absorption in mice
- (2021) Lili Ding et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bile acids and their receptors in metabolic disorders
- (2021) Stefano Fiorucci et al. PROGRESS IN LIPID RESEARCH
- Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol
- (2021) James M. Eng et al. Cells
- Inverse Association of Serum Adipsin with the Remission of Nonalcoholic Fatty-Liver Disease: A 3-Year Community-Based Cohort Study
- (2021) Yingying Gu et al. ANNALS OF NUTRITION AND METABOLISM
- Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling
- (2021) Silvia Marchianò et al. FASEB JOURNAL
- Linking liver metabolic and vascular disease via bile acid signaling
- (2021) Stefano Fiorucci et al. TRENDS IN MOLECULAR MEDICINE
- Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study
- (2021) Mary E. Rinella et al. JOURNAL OF HEPATOLOGY
- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
- (2020) Rod S. Taylor et al. GASTROENTEROLOGY
- Cenicriviroc Treatment for Adults with Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study
- (2020) Vlad Ratziu et al. HEPATOLOGY
- Of mice and men: Murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism
- (2020) Sara Straniero et al. JOURNAL OF LIPID RESEARCH
- Is CYP2C70 the key to new mouse models to understand bile acids in humans?
- (2020) Grace L. Guo et al. JOURNAL OF LIPID RESEARCH
- Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis
- (2020) Donatella Chianelli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Why do so many NASH trials fail?
- (2020) Vlad Ratziu et al. GASTROENTEROLOGY
- Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)
- (2020) Stefano Fiorucci et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis
- (2020) Adriana Carino et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC
- (2019) Michael Trauner et al. HEPATOLOGY
- Deficiency of both farnesoid X receptor and Takeda G protein-coupled receptor 5 exacerbated liver fibrosis in mice
- (2019) Jessica M. Ferrell et al. HEPATOLOGY
- Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis
- (2019) Maren H. Harms et al. JOURNAL OF HEPATOLOGY
- Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation
- (2019) Adriana Carino et al. Nutrients
- Hepatocyte Elovl6 determines ceramide acyl‐chain length and hepatic insulin sensitivity in mice
- (2019) Takashi Matsuzaka et al. HEPATOLOGY
- Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH
- (2019) Adriana Carino et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitis
- (2019) Vasiliki Venetsanaki et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis
- (2019) Mohammad Shadab Siddiqui et al. JOURNAL OF HEPATOLOGY
- Identification of Key Genes and Signaling Pathways Associated with the Progression of Gastric Cancer
- (2019) Chaoran Yu et al. PATHOLOGY & ONCOLOGY RESEARCH
- Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
- (2018) Chun Kit Hung et al. Clinics in Liver Disease
- Bile Acid Metabolism in Liver Pathobiology
- (2018) John Y. L. Chiang et al. GENE EXPRESSION
- Future trends in the treatment of non-alcoholic steatohepatitis
- (2018) Stefano Fiorucci et al. PHARMACOLOGICAL RESEARCH
- Bile Acids Activated Receptors Regulate Innate Immunity
- (2018) Stefano Fiorucci et al. Frontiers in Immunology
- Association of Circulating Adipsin, Visfatin, and Adiponectin with Nonalcoholic Fatty Liver Disease in Adults: A Case-Control Study
- (2018) Yun Qiu et al. ANNALS OF NUTRITION AND METABOLISM
- Animal models of atherosclerosis
- (2017) Besa Emini Veseli et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
- (2017) Na Jiao et al. GUT
- The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis
- (2017) Michele Biagioli et al. JOURNAL OF IMMUNOLOGY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis
- (2017) Adriana Carino et al. Scientific Reports
- Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice
- (2017) Adriana Carino et al. Scientific Reports
- Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations
- (2016) Zaki A. Sherif et al. DIGESTIVE DISEASES AND SCIENCES
- Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice
- (2016) Lili Ding et al. HEPATOLOGY
- Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
- (2016) Juan P. Arab et al. HEPATOLOGY
- Differential Roles of Cell Death-inducing DNA Fragmentation Factor-α-like Effector (CIDE) Proteins in Promoting Lipid Droplet Fusion and Growth in Subpopulations of Hepatocytes
- (2016) Wenyi Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolic interplay between white, beige, brown adipocytes and the liver
- (2016) Ludger Scheja et al. JOURNAL OF HEPATOLOGY
- Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans
- (2016) Shogo Takahashi et al. JOURNAL OF LIPID RESEARCH
- Management of NAFLD: a stage-based approach
- (2016) Mary E. Rinella et al. Nature Reviews Gastroenterology & Hepatology
- TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice
- (2015) Anne K McGavigan et al. GUT
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Design, Synthesis, and Biological Evaluation of Potent Dual Agonists of Nuclear and Membrane Bile Acid Receptors
- (2014) Claudio D’Amore et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
- (2013) Howard C. Masuoka et al. Annals of the New York Academy of Sciences
- The role of Ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review
- (2013) Zun Xiang et al. BMC GASTROENTEROLOGY
- Extrahepatic complications of nonalcoholic fatty liver disease
- (2013) Matthew J. Armstrong et al. HEPATOLOGY
- Effect of Statin Therapy on the Progression of Common Carotid Artery Intima-Media Thickness: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2012) Yubei Huang et al. Journal of Atherosclerosis and Thrombosis
- Treatment of NASH with ursodeoxycholic acid: Pro
- (2012) Vlad Ratziu Clinics and Research in Hepatology and Gastroenterology
- High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial
- (2010) Ulrich F. H. Leuschner et al. HEPATOLOGY
- Bile acids: regulation of synthesis
- (2009) John Y. L. Chiang JOURNAL OF LIPID RESEARCH
- The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice
- (2009) Hervé Guillou et al. PROGRESS IN LIPID RESEARCH
- Pathogenesis of non-alcoholic fatty liver disease
- (2009) J. K. Dowman et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α-hydroxylase gene expression
- (2008) Kwang-Hoon Song et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search